Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3977361 | Brachytherapy | 2010 | 6 Pages |
Abstract
The use of supplemental EBRT in men with low-risk prostate cancer treated with brachytherapy has decreased since 2001. This change in practice patterns suggests gradual adoption of the 1999 ABS practice guidelines.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Arthur K. Cheung, Ming-Hui Chen, Brian J. Moran, Michelle H. Braccioforte, Daniel E. Dosoretz, Sharon Salenius, Michael Katin, Rudi Ross, Anthony V. D'Amico,